Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-020165
Filing Date
2021-08-16
Accepted
2021-08-16 16:16:24
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20210630_10q.htm   iXBRL 10-Q 1424222
2 EXHIBIT 10.1 ex_274502.htm EX-10.1 220163
3 EXHIBIT 31.1 ex_274503.htm EX-31.1 8114
4 EXHIBIT 31.2 ex_274504.htm EX-31.2 8150
5 EXHIBIT 32.1 ex_274505.htm EX-32.1 5998
  Complete submission text file 0001437749-21-020165.txt   5880631

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acrx-20210630.xsd EX-101.SCH 53184
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20210630_cal.xml EX-101.CAL 37259
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20210630_def.xml EX-101.DEF 325851
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20210630_lab.xml EX-101.LAB 288066
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20210630_pre.xml EX-101.PRE 347217
11 EXTRACTED XBRL INSTANCE DOCUMENT acrx20210630_10q_htm.xml XML 854082
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 211178413
SIC: 2834 Pharmaceutical Preparations